DK0673390T3 - Deltalignende gen, som udtrykkes i neuroendokrine tumorer - Google Patents

Deltalignende gen, som udtrykkes i neuroendokrine tumorer

Info

Publication number
DK0673390T3
DK0673390T3 DK94903572T DK94903572T DK0673390T3 DK 0673390 T3 DK0673390 T3 DK 0673390T3 DK 94903572 T DK94903572 T DK 94903572T DK 94903572 T DK94903572 T DK 94903572T DK 0673390 T3 DK0673390 T3 DK 0673390T3
Authority
DK
Denmark
Prior art keywords
dlk
partial
neuroendocrine tumors
genes expressed
neuroendocrine
Prior art date
Application number
DK94903572T
Other languages
Danish (da)
English (en)
Inventor
Jorge Laborda
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0673390T3 publication Critical patent/DK0673390T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94903572T 1992-12-11 1993-12-10 Deltalignende gen, som udtrykkes i neuroendokrine tumorer DK0673390T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98953792A 1992-12-11 1992-12-11
PCT/US1993/012015 WO1994013701A2 (en) 1992-12-11 1993-12-10 Delta-like gene expressed in neuroendocrine tumors

Publications (1)

Publication Number Publication Date
DK0673390T3 true DK0673390T3 (da) 2000-11-13

Family

ID=25535199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903572T DK0673390T3 (da) 1992-12-11 1993-12-10 Deltalignende gen, som udtrykkes i neuroendokrine tumorer

Country Status (11)

Country Link
US (2) US5644031A (de)
EP (2) EP1013762A3 (de)
JP (1) JPH08509358A (de)
AT (1) ATE194653T1 (de)
AU (1) AU677623B2 (de)
CA (1) CA2151455A1 (de)
DE (1) DE69329037T2 (de)
DK (1) DK0673390T3 (de)
ES (1) ES2151542T3 (de)
PT (1) PT673390E (de)
WO (1) WO1994013701A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101728A (en) * 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
US5856441A (en) * 1991-05-03 1999-01-05 Yale University Serrate fragments and derivatives
PT673390E (pt) * 1992-12-11 2001-01-31 Us Health Genes semelhantes a delta expressos em tumores neuroendocrinos
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US20050158859A1 (en) * 1995-09-29 2005-07-21 Yale University Manipulation of non-terminally differentiated cells using the Notch pathway
WO1997031647A1 (en) * 1996-03-01 1997-09-04 Imclone Systems Incorporated Use of delta-like protein to inhibit the differentiation of stem cells
US6121045A (en) * 1997-04-04 2000-09-19 Millennium Biotherapeutics, Inc. Human Delta3 nucleic acid molecules
US20060122373A1 (en) * 1997-04-04 2006-06-08 Millennium Pharmaceuticals, Inc. Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
US8084258B2 (en) 1999-07-12 2011-12-27 University Of Basel Manipulation of tissue of organ type using the notch pathway
EP1421179A1 (de) * 2001-08-24 2004-05-26 Nsgene A/S Isolierung von zellen aus neuralzellpopulationen unter verwendung von antikörpern gegen fa1/dlk1
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
ES2345493T3 (es) * 2003-11-28 2010-09-24 Kanagawa Academy Of Science And Technology Metodo de deteccion de cancer de higado, diagnostico de cancer de higado y remedio para el cancer.
WO2006026051A2 (en) * 2004-08-03 2006-03-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selections of genes and methods of using the same for diagnosis, prognosis and for targeting the therapy of neuroblastoma
CN103073641B (zh) * 2006-11-10 2015-01-21 株式会社立富泰克 在体内具有抗肿瘤活性的抗人Dlk-1抗体
ES2527521T3 (es) 2008-03-17 2015-01-26 Livtech Inc. Anticuerpos antihumanos frente a Dlk-1 que tienen actividad antitumoral
US8956869B2 (en) 2009-09-29 2015-02-17 Kyushu University, National University Corporation Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
KR100982170B1 (ko) * 2010-03-16 2010-09-15 한국생명공학연구원 ＤＬＫ１―Ｆｃ 융합 단백질을 유효성분으로 함유하는 암 전이 억제용 조성물
ES2381161B1 (es) * 2010-10-21 2013-04-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de dlk1 como inhibidor de angiogénesis.
ES2665341T3 (es) 2012-10-03 2018-04-25 Chiome Bioscience Inc. Anticuerpo anti-DLK-1 humana con actividad antitumoral in vivo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT673390E (pt) * 1992-12-11 2001-01-31 Us Health Genes semelhantes a delta expressos em tumores neuroendocrinos

Also Published As

Publication number Publication date
DE69329037D1 (de) 2000-08-17
CA2151455A1 (en) 1994-06-23
JPH08509358A (ja) 1996-10-08
US5644031A (en) 1997-07-01
WO1994013701A3 (en) 1995-11-23
ES2151542T3 (es) 2001-01-01
EP0673390B1 (de) 2000-07-12
EP1013762A3 (de) 2000-10-11
ATE194653T1 (de) 2000-07-15
DE69329037T2 (de) 2001-03-22
WO1994013701A2 (en) 1994-06-23
AU677623B2 (en) 1997-05-01
AU5746894A (en) 1994-07-04
EP1013762A2 (de) 2000-06-28
PT673390E (pt) 2001-01-31
US5580738A (en) 1996-12-03
EP0673390A1 (de) 1995-09-27

Similar Documents

Publication Publication Date Title
DK0673390T3 (da) Deltalignende gen, som udtrykkes i neuroendokrine tumorer
DE69940969D1 (de) Detektion von neoplasien durch speichelanalyse
NO985150D0 (no) Antigenbindende fragment som sµrlig sporer kreftceller, nukleoid som koder nevnte fragment, samt bruk av dette ved forebygging og pÕvisning av kreft
IL84866A0 (en) Method for detecting tumors
DE3574730D1 (de) Monoklonaler antikoerper gegen ein humanes tumor-karzinom-assoziiertes antigen.
DE3783277D1 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
IE810451L (en) Tumour localization with labeled antibodies
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DE3482905D1 (de) Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.
DE69024659D1 (de) Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
EP0226888A3 (de) Für das Isoenzym II der Galactosyltransferase spezifische monoklonale Antikörper und deren Verwendung in immunologischen Testen für Krebs
DK185086A (da) Tumor-associeret antigen, antistoffer specifikke herfor samt fremgangsmaade til disses fremstilling
ATE230024T1 (de) Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
NO961138L (no) Protein kinase C aktivatorer og anvendelse derav for å redusere ekspresjon av celleantigener
DE3679048D1 (de) Als laeppmittel geeignetes umkleidetes schleifmittel.
ATE135468T1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
ATE61670T1 (de) Immuntest zum nachweis von antikoerpern gegen dns.
EP0295305A4 (de) Monoklonaler antikörper, spezifisch gegen tumorzellenoberflächengangliosid und denselben herstellendes hydridom.
DE69114546D1 (de) Neue Verwendung für einen monoklonalen Antikörper.
SU565015A1 (ru) Бетонна смесь
SU640003A1 (ru) Стыковое соединение
DE3882066D1 (de) Monoclonaler antikoerper gegen menschliches lungenadenokarzinom.